Borosil Glass Works Shares Triple in One Year Amid Strong Revenue and EBIDTA Growth Diodes Inc Senior VP Emily Yang Sells 545280 in Company Stock Microsofts GitHub Gains Users but Faces Outages and Competition in AIPowered Coding Market US Productivity Growth Slows in Q4 While Unit Labor Costs Accelerate ET Alpha Wealth Summit Leading Investors to Chart Indias Investment Roadmap for the Next Decade Sebi Proposes Intraday Option Strike Additions to Manage Market Volatility Northpointe Bancshares Inc NPB Q1 2026 Earnings Earnings Slightly Miss Estimates Shares Dip Personalis Inc PSNL Q1 2026 Earnings EPS Misses Estimates While Stock Rises 267 LTC Properties Inc Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Vista Gold Corp Q1 2026 Earnings PreRevenue Stage Maintains Focus on Paredones Amarillos AGAI Q1 2025 Earnings Net Loss Persists as Esports Firm Positions for Growth SUNE Q2 2024 Earnings NarrowerThanExpected Loss Amid Ongoing Restructuring Duke Energy DUKB Preferred Stock Holds Steady Near 24 Amid Modest Gains Global Engine Group Holding Limited GLE Surges 17 Testing Key Resistance at 053 Dover Corporation DOV Shows Modest Uptick Testing Key Resistance Levels Allstate ALL Holds Steady Near Key Support After Modest Pullback PPlus Trust GSC2 PYT Holds Steady at 2339 as Support and Resistance Levels Define Trading Range LFCR Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction HNNA Q1 2026 Earnings Asset Manager Posts 024 EPS as Stock Climbs Nearly 2 EXLS Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Pending FB Financial Q1 2026 Earnings EPS Slightly Misses Estimates Despite Positive Market Response FMC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Challenges Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Resilient Underwriting Results Medpace MEDP Faces Securities Class Action Lead Plaintiff Deadline on June 8 2026 Aprea Therapeutics Inc APRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Clinical Progress LENZ Therapeutics LENZ Edges Lower as Stock Tests Support at 730